• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恩杂他胺治疗伴有高氨血症和肾功能损害的双相情感障碍:一例报告

Endoxifen in Bipolar Disorder With Hyperammonemia and Renal Impairment: A Case Report.

作者信息

Gautam Nikhil, Abhilasha Pallavi

机构信息

Department of Psychiatry, Christian Medical College and Hospital, Ludhiana, IND.

出版信息

Cureus. 2025 Jan 3;17(1):e76839. doi: 10.7759/cureus.76839. eCollection 2025 Jan.

DOI:10.7759/cureus.76839
PMID:39897274
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11787948/
Abstract

Lithium, divalproex, and oxcarbazepine are commonly prescribed medications used for the management of bipolar disorder, but each of these drugs comes with its own gamut of adverse effects that make these agents unfavorable in certain medical conditions. Endoxifen, a protein kinase C inhibitor and selective estrogen receptor modulator, originally used in breast cancer treatment, has recently emerged as a potential therapeutic option for managing manic episodes in bipolar disorder. This case report highlights the use of endoxifen in the management of severe manic symptoms of bipolar disorder in a 65-year-old male patient with medical comorbidities arising from traditional mood stabilizer drugs and its potential as an alternative treatment over such drugs.

摘要

锂盐、丙戊酸镁和奥卡西平是常用于治疗双相情感障碍的处方药,但这些药物都有各自一系列的不良反应,这使得它们在某些医疗情况下并不适用。4-羟基他莫昔芬是一种蛋白激酶C抑制剂和选择性雌激素受体调节剂,最初用于乳腺癌治疗,最近已成为治疗双相情感障碍躁狂发作的一种潜在治疗选择。本病例报告强调了4-羟基他莫昔芬在一名65岁男性双相情感障碍患者严重躁狂症状管理中的应用,该患者因传统心境稳定剂药物出现了合并症,以及它作为此类药物替代治疗的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/042d/11787948/fbaf6a580eff/cureus-0017-00000076839-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/042d/11787948/fbaf6a580eff/cureus-0017-00000076839-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/042d/11787948/fbaf6a580eff/cureus-0017-00000076839-i01.jpg

相似文献

1
Endoxifen in Bipolar Disorder With Hyperammonemia and Renal Impairment: A Case Report.恩杂他胺治疗伴有高氨血症和肾功能损害的双相情感障碍:一例报告
Cureus. 2025 Jan 3;17(1):e76839. doi: 10.7759/cureus.76839. eCollection 2025 Jan.
2
Efficacy and safety of endoxifen in bipolar disorder: A systematic review.双相障碍中环苯三酚的疗效和安全性:系统评价。
Hum Psychopharmacol. 2024 Jul;39(4):e2899. doi: 10.1002/hup.2899. Epub 2024 Apr 29.
3
The Antimanic Effect of Endoxifen in Patients with Bipolar Disorder with Renal Comorbidities: Case Series.依他莫昔芬对合并肾脏疾病的双相情感障碍患者的抗躁狂作用:病例系列
Indian J Psychol Med. 2024 Sep 21:02537176241279547. doi: 10.1177/02537176241279547.
4
[Antipsychotics in bipolar disorders].[双相情感障碍中的抗精神病药物]
Encephale. 2004 Sep-Oct;30(5):417-24. doi: 10.1016/s0013-7006(04)95456-5.
5
Endoxifen: A new, protein kinase C inhibitor to treat acute and mixed mania associated with bipolar I disorder.依地福新:一种新型蛋白激酶 C 抑制剂,用于治疗与双相 I 型障碍相关的急性和混合躁狂症。
Bipolar Disord. 2021 Sep;23(6):595-603. doi: 10.1111/bdi.13041. Epub 2021 Jan 9.
6
Maintenance therapies in bipolar disorder: focus on randomized controlled trials.双相情感障碍的维持治疗:聚焦于随机对照试验。
Aust N Z J Psychiatry. 2005 Aug;39(8):652-61. doi: 10.1080/j.1440-1614.2005.01649.x.
7
Effectiveness and medical costs of divalproex versus lithium in the treatment of bipolar disorder: results of a naturalistic clinical trial.丙戊酸镁与锂盐治疗双相情感障碍的疗效及医疗费用:一项自然临床试验的结果
J Affect Disord. 2005 Jun;86(2-3):183-93. doi: 10.1016/j.jad.2005.01.002.
8
Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder.丙戊酸、丙戊酸盐及丙戊酸镁在双相情感障碍维持治疗中的应用
Cochrane Database Syst Rev. 2001(3):CD003196. doi: 10.1002/14651858.CD003196.
9
[Treatment of manic phases of bipolar disorder: critical synthesis of international guidelines].[双相情感障碍躁狂发作期的治疗:国际指南的批判性综述]
Encephale. 2014 Sep;40(4):330-7. doi: 10.1016/j.encep.2013.10.007. Epub 2014 Feb 7.
10
Medication treatment of bipolar disorder 2000: a summary of the expert consensus guidelines.2000年双相情感障碍的药物治疗:专家共识指南摘要
J Psychiatr Pract. 2000 Jul;6(4):197-211. doi: 10.1097/00131746-200007000-00004.

本文引用的文献

1
Risk factors and outcome of hyperammonaemia in people with epilepsy.癫痫患者高血氨症的风险因素和结果。
J Neurol. 2022 Dec;269(12):6395-6405. doi: 10.1007/s00415-022-11304-7. Epub 2022 Jul 30.
2
Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.全球、区域和国家 204 个地区 1990-2019 年 12 种精神障碍疾病的负担:基于 2019 年全球疾病负担研究的系统分析。
Lancet Psychiatry. 2022 Feb;9(2):137-150. doi: 10.1016/S2215-0366(21)00395-3. Epub 2022 Jan 10.
3
Old Age Bipolar Disorder-Epidemiology, Aetiology and Treatment.
老年双相情感障碍 - 流行病学、病因学和治疗。
Medicina (Kaunas). 2021 Jun 8;57(6):587. doi: 10.3390/medicina57060587.
4
Endoxifen: A new, protein kinase C inhibitor to treat acute and mixed mania associated with bipolar I disorder.依地福新:一种新型蛋白激酶 C 抑制剂,用于治疗与双相 I 型障碍相关的急性和混合躁狂症。
Bipolar Disord. 2021 Sep;23(6):595-603. doi: 10.1111/bdi.13041. Epub 2021 Jan 9.
5
Lithium and nephrotoxicity: a literature review of approaches to clinical management and risk stratification.锂与肾毒性:临床管理和风险分层方法的文献综述。
BMC Nephrol. 2018 Nov 3;19(1):305. doi: 10.1186/s12882-018-1101-4.
6
Lesson of the month 1: Sodium valproate-induced encephalopathy.本月课程 1:丙戊酸钠诱导性脑病。
Clin Med (Lond). 2018 Oct;18(5):430-432. doi: 10.7861/clinmedicine.18-5-430.
7
Role of Protein Kinase C in Bipolar Disorder: A Review of the Current Literature.蛋白激酶C在双相情感障碍中的作用:当前文献综述
Mol Neuropsychiatry. 2017 Nov;3(2):108-124. doi: 10.1159/000480349. Epub 2017 Oct 7.
8
Review and Meta-Analysis of Epidemiologic Studies of Adult Bipolar Disorder.成人双相情感障碍的流行病学研究综述与荟萃分析。
J Clin Psychiatry. 2017 Nov/Dec;78(9):e1259-e1269. doi: 10.4088/JCP.16r11165.
9
Clinical Practice Guidelines for Management of Bipolar Disorder.双相情感障碍管理临床实践指南
Indian J Psychiatry. 2017 Jan;59(Suppl 1):S51-S66. doi: 10.4103/0019-5545.196974.
10
Lithium side effects and toxicity: prevalence and management strategies.锂的副作用与毒性:发生率及管理策略
Int J Bipolar Disord. 2016 Dec;4(1):27. doi: 10.1186/s40345-016-0068-y. Epub 2016 Dec 17.